系统医学2024,Vol.9Issue(3) :54-57.DOI:10.19368/j.cnki.2096-1782.2024.03.054

甲磺酸倍他司汀片结合活血化瘀法治疗感应神经性耳聋的临床探讨

Clinical Investigation of Betahistine Mesylate Tablets Combined with the Method of Activating Blood and Removing Blood Stasis in the Treatment of Sensorineural Deafness

褚云锋 黄晶晶 孙燕 陈骁锐 陶丹丹
系统医学2024,Vol.9Issue(3) :54-57.DOI:10.19368/j.cnki.2096-1782.2024.03.054

甲磺酸倍他司汀片结合活血化瘀法治疗感应神经性耳聋的临床探讨

Clinical Investigation of Betahistine Mesylate Tablets Combined with the Method of Activating Blood and Removing Blood Stasis in the Treatment of Sensorineural Deafness

褚云锋 1黄晶晶 1孙燕 1陈骁锐 1陶丹丹1
扫码查看

作者信息

  • 1. 张家港市中医医院耳鼻喉科,江苏张家港 215600
  • 折叠

摘要

目的 研究甲磺酸倍他司汀片和活血化瘀法联合应用于感应神经性耳聋治疗中的临床疗效.方法 选取2020年8月—2022年8月张家港市中医医院收治的48例感应神经性耳聋患者作为研究对象,按随机数表法分为两组,对照组(n=24)使用甲磺酸倍他司汀片治疗,观察组(n=24)使用甲磺酸倍他司汀片联合活血化瘀法治疗.比较两组患者的疗效和不良反应发生情况.结果 治疗后,观察组的耳鸣评分(0.39±0.08)分、耳胀闷感评分(0.26±0.07)分、恶心呕吐评分(0.49±0.08)分以及眩晕评分(0.38±0.07)分均低于对照组,差异有统计学意义(t=25.648、25.390、14.176、26.301,P均<0.05);治疗后,观察组的听力测试值低于对照组,差异有统计学意义(P<0.05);两组患者的不良反应发生率对比,差异无统计学意义(P>0.05).结论 感应神经性耳聋患者应用甲磺酸倍他司汀片和活血化瘀法治疗可有效改善疾病症状,提升听力水平,且具有较高的安全性.

Abstract

Objective To study the clinical efficacy of the combined application of betahistine mesylate tablets and the method of activating blood and removing blood stasis in the treatment of sensorineural deafness.Methods A total of 48 patients with sensorineural deafness treated in Zhangjiagang Hospital of Traditional Chinese Medicine from Au-gust 2020 to August 2022 were selected as the study objects,and were divided into two groups by random number table method.The control group(n=24)was treated with betahistine mesylate tablet,and the observation group(n=24)was treated with betahistine mesylate tablet combined with blood-activating and blood-removing method.The efficacy and occurrence of adverse reactions were compared between the two groups of patients.Results After treatment,the tinnitus score(0.39±0.08)points,ear flatulence score(0.26±0.07)points,nausea and vomiting score(0.49±0.08)points and vertigo score(0.38±0.07)points of the observation group were all lower than those of the control group,and the differences were statistically significant(t=25.648,25.390,14.176,26.301,all P<0.05).After treatment,the hear-ing test value of the observation group was lower than that of the control group,and the difference was statistically sig-nificant(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups of patients(P>0.05).Conclusion The application of betahistine mesylate tablets and activating blood circulation to re-move blood stasis in patients with sensorineural deafness can effectively improve the disease symptoms,improve the hearing level,and have a high safety.

关键词

甲磺酸倍他司汀片/活血化瘀法/感应神经性耳聋/听力水平/中医证候

Key words

Betahistine mesylate tablets/Activating blood and removing blood stasis method/Sensorineural deafness/Hearing level/Chinese medicine evidence

引用本文复制引用

出版年

2024
系统医学

系统医学

ISSN:
参考文献量18
段落导航相关论文